Eduardo Beltrán-Sarmiento

Eduardo Beltrán-Sarmiento

Auto-generated profile, based on publicly available information

Eduardo Beltrán-Sarmiento

Hospital Militar, Secretaría de la Defensa Nacional, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
EBEduardo Beltrán-Sarmiento
Eduardo Beltrán-Sarmiento
CACindy K Arregoitia-Sarabia
Cindy K Arregoitia-Sarabia
EFEsaú Floriano-Sánchez
Esaú Floriano-Sánchez
RSRoberto Sandoval-Pacheco
Roberto Sandoval-Pacheco
DGDiana E Galván-Hernández
Diana E Galván-Hernández
Noemi Cardenas-RodríguezNoemi Cardenas-Rodríguez
Noemi Cardenas-Rodríguez
Epilepsy is a neurological disorder that can produce brain injury and neuronal death. Several factors such as oxidative stress have been implicated in epileptogenesis. Valproic acid (VPA) is a widely used drug for the treatment of epilepsy, but the mechanisms underlying these benefits are complex and still not fully understood. The objective of this study was to evaluate, for the first time, the effects of VPA on the oxidant‐antioxidant status in Mexican epileptic children before and after 6 or 12 months of treatment with VPA by determining the activities of several plasmatic antioxidant enzymes (glutathione reductase (GR), glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT)) and oxidant marker (malondialdehyde (MDA), hydrogen peroxide (H2O2), 8‐hydroxy‐2‐deoxyguanosine (8‐OHdG), and 3‐nitrotyrosine (3‐NT) levels) profiles. The possible relationships between these markers and some clinicopathological factors were also evaluated. Plasma samples were obtained from the peripheral blood of 16 healthy children and 32 patients diagnosed with epilepsy, and antioxidant/oxidant markers were measured spectrometrically. Significant decreases in all antioxidant enzyme activities, with the exception of GPx, and increases in all oxidant markers in epileptic subjects versus healthy children were observed. Interestingly, all these effects reverted after VPA monotherapy, although the results were different depending on the treatment period (6 or 12 months). These changes were contingent upon brain imaging findings, type of epilepsy, etiology of epilepsy, and the efficacy of 6 months of VPA monotherapy. Significant and positive correlations of GPx and SOD activities and H2O2 and 8‐OHdG levels with the age of children at the beginning of treatment were observed. H2O2 levels were also positively correlated with number of seizures before VPA monotherapy. VPA showed significant antioxidant effects decreasing seizure activity, possibly depending on the presence of cerebral structural alterations, treatment time, and age.

29 January 2024 in Archives of Medical Research
Verified
Journal Article
Closed access
GCGraciela Cárdenas
Graciela Cárdenas
MCMaría Chávez-Canales
María Chávez-Canales
AEAna María Espinosa
Ana María Espinosa
AJAntonio Jordán-Ríos
Antonio Jordán-Ríos
DMDaniel Anica Malagon
Daniel Anica Malagon
ESEdda Sciutto
Edda Sciutto

15 January 2016
Verified
Journal Article
Closed access
EBEduardo Beltran-Sarmiento
Eduardo Beltran-Sarmiento
EFEsaú Floriano-Sánchez
Esaú Floriano-Sánchez
Cindy BandalaCindy Bandala
Cindy Bandala
ELEleazar Lara-Padilla
Eleazar Lara-Padilla
Noemi Cardenas-RodríguezNoemi Cardenas-Rodríguez
Noemi Cardenas-Rodríguez

10 July 2025 in Revista de Sanidad Militar
Verified
Journal Article
Closed access
HZHarold Christian Zebadua-Castellanos
Harold Christian Zebadua-Castellanos
EBEduardo Beltrán-Sarmiento
Eduardo Beltrán-Sarmiento
MVMarco Antonio Vargas-Hernández
Marco Antonio Vargas-Hernández
Periodontal disease (PD) has been one of the most worrisome global public health milestones throughout history. This disease has traditionally been considered as a chronic inflammatory pathology of multifactorial origin, whose primary etiological factor is a highly organized biofilm of bacterial origin in an ecological niche. Periodontitis is a complex disease with multiple components, some based on genetics, some caused by epigenetic influences, and others that are modifiable because they are related to patient behaviors, medications, or environmental factors such as toxicological habits; even food or nutritional, since the mere presence of the microorganism is not enough to cause the disease per se. Periodontitis might be associated with reduced local antioxidant defense and suggested that systemic and local TAOC (Method of Assessment of Total Antioxidant Capacity) levels in ChP might reflect increased oxygen radical activity during periodontal inflammation and may be restored. to subject control levels by successful non surgical therapy. Vitamin C aids in the bactericidal activity of PMN´s and monocytes/macrophages, providing enhanced nitric oxide synthesis. At present, there are no studies available on the intracellular storage of vitamin C in leukocytes of patients with periodontitis. Provided that vitamin C plays a protective role for the development and/or severity of periodontal disease as suggested in the literature, it can be hypothesized that its concentration in plasma, PMN and peripheral blood mononuclear cells.